Great Find Antihama! Case closed. We know they have the MOA clearly identified and have figured out how to tweak the effectiveness in the process. They will easily be able to demonstrate comparability of vaccine output from both methods. I also recall reading that the Flaskworks process actually produced more consistent output than the artisan (manual) processing is some testing.
There are a lot of people who're making this sound far more difficult than you're saying. Is it possible that it will be much tougher to gain approval in the US than the UK, or if we have UK approval and it's proven to be working in patients should it be accepted on that basis.